Tentt

Arcellx Acquired by Gilead Sciences — Healthcare M&A

Announced
HealthcareMerger

Deal Summary

Gilead Sciences to acquire Arcellx via tender offer and follow-on merger for $115/share plus up to $5 CVR tied to anito-cel sales.

Key Details

Transaction
Gilead Sciences acquires Arcellx
Deal Size
Over $100M
Reported Value
$6.0 billion

Source

Read full article on news.google.com

via GN - signed definitive agreement · February 23, 2026

Related Deals